Neurimmune enters into a collaboration and license agreement with AstraZeneca to develop and commercialize NI006

/PRNewswire/ -- Neurimmune AG today announced that it has entered into an exclusive global collaboration and license agreement with Alexion, AstraZeneca's Rare...

Related Keywords

Zurich ,Züsz ,Switzerland ,Jan Grimm ,Martin Meier Pfister ,Christoph Hock ,Fabian Buller , ,Rare Disease ,Reverse Translational ,Neurimmune ,Health Care Amp Hospitals ,Biotechnology ,Medical Pharmaceuticals ,Licensing ,